Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Clinical Science (London, England : 1979)
|
September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
Gut
|
April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
Marina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 13, 2026
Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma
Luz A Martínez-Pérez, M Ujue Latasa, Iker Uriarte, et al.
Journal of Hepatology
|
June 11, 2023
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Alex Clavería-Cabello, Jose Maria Herranz, Maria Ujue Latasa, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 14, 2025
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
Daniel Oyon, Amaya Lopez-Pascual, Borja Castello-Uribe, et al.
Gut
|
July 21, 2021
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
Maria Arechederra, María Rullán, Irene Amat, et al.
Cell Reports. Medicine
|
April 2, 2026
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma
Elena Adan-Villaescusa, Borja Castello-Uribe, Iker Uriarte, et al.
Gut
|
September 12, 2024
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Jasmin Elurbide, Leticia Colyn, Maria U Latasa, et al.
Hepatology (Baltimore, Md.)
|
November 22, 2020
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
Leticia Colyn, Marina Bárcena-Varela, Gloria Álvarez-Sola, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 26, 2022
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
Leticia Colyn, Gloria Alvarez-Sola, M Ujue Latasa, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Clinical Science (London, England : 1979)
|
September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
Gut
|
April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
Marina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 13, 2026
Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma
Luz A Martínez-Pérez, M Ujue Latasa, Iker Uriarte, et al.
Journal of Hepatology
|
June 11, 2023
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Alex Clavería-Cabello, Jose Maria Herranz, Maria Ujue Latasa, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 14, 2025
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
Daniel Oyon, Amaya Lopez-Pascual, Borja Castello-Uribe, et al.
Gut
|
July 21, 2021
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
Maria Arechederra, María Rullán, Irene Amat, et al.
Cell Reports. Medicine
|
April 2, 2026
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma
Elena Adan-Villaescusa, Borja Castello-Uribe, Iker Uriarte, et al.
Gut
|
September 12, 2024
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Jasmin Elurbide, Leticia Colyn, Maria U Latasa, et al.
Hepatology (Baltimore, Md.)
|
November 22, 2020
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
Leticia Colyn, Marina Bárcena-Varela, Gloria Álvarez-Sola, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 26, 2022
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
Leticia Colyn, Gloria Alvarez-Sola, M Ujue Latasa, et al.
Page
of 4